Literature DB >> 8525023

Three-dimensional treatment planning and conformal radiation therapy: preliminary evaluation.

C A Perez1, J A Purdy, W Harms, R Gerber, M V Graham, J W Matthews, W Bosch, R Drzymala, B Emami, S Fox.   

Abstract

Preliminary clinical results are presented for 209 patients with cancer who had treatment planned on our three-dimensional radiation treatment planning (3-D RTP) system and were treated with external beam conformal radiation therapy. Average times (min) for CT volumetric simulation were: 74 without or 84 with contrast material; 36 for contouring of tumor/target volume and 44 for normal anatomy; 78 for treatment planning; 53 for plan evaluation/optimization; and 58 for verification simulation. Average time of daily treatment sessions with 3-D conformal therapy or standard techniques was comparable for brain, head and neck, thoracic, and hepatobiliary tumors (11.8-14 min and 11.5-12.1, respectively). For prostate cancer patients treated with 3-D conformal technique and Cerrobend blocks, mean treatment time was 19 min; with multileaf collimation it was 14 min and with bilateral arc rotation, 9.8 min. Acute toxicity was comparable to or lower than with standard techniques. Sophisticated 3-D RTP and conformal irradiation can be performed in a significant number of patients at a reasonable cost. Further efforts, including dose-escalation studies, are necessary to develop more versatile and efficient 3-D RTP systems and to enhance the cost benefit of this technology in treatment of patients with cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8525023     DOI: 10.1016/0167-8140(95)01566-y

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  Radiotherapy Planning Complexity and Survival after Treatment of Advanced Stage Lung Cancer in the Elderly.

Authors:  Benjamin Goldsmith; Jamie Cesaretti; Juan P Wisnivesky
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

Review 2.  The economic costs of early stage prostate cancer.

Authors:  Christopher S Saigal; Mark S Litwin
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?

Authors:  R L Eakin; M I Saunders
Journal:  Ulster Med J       Date:  2000-11

4.  Focused very high-energy electron beams as a novel radiotherapy modality for producing high-dose volumetric elements.

Authors:  K Kokurewicz; E Brunetti; G H Welsh; S M Wiggins; M Boyd; A Sorensen; A J Chalmers; G Schettino; A Subiel; C DesRosiers; D A Jaroszynski
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

5.  A Safe and Practical Cycle for Team-Based Development and Implementation of In-House Clinical Software.

Authors:  Jean M Moran; Kelly C Paradis; Scott W Hadley; Martha M Matuszak; Charles S Mayo; Katherine Woch Naheedy; Xiaoping Chen; Dale W Litzenberg; James Irrer; Maria G Ditman; Pam Burger; Marc L Kessler
Journal:  Adv Radiat Oncol       Date:  2021-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.